8-K 1 ivax-8k.txt CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------------------------- FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 5, 2002 IVAX CORPORATION (Exact Name of Registrant as Specified in its Charter) Florida 1-09623 16-1003559 (State or Other Jurisdiction of (Commission File Number) (IRS Employer Incorporation) Identification No.) 4400 Biscayne Boulevard, Miami, Florida 33137 (Address of Principal Executive Offices) (305) 575-6000 (Registrant's Telephone Number, Including Area Code) N/A (Former Name or Former Address, if Changed since Last Report) ----------------------------------- ITEM 5. Other Events. On March 5, 2002, IVAX Corporation issued 159,730 shares (the "Shares") of its common stock, pursuant to its Registration Statement on Form S-3, Registration No. 333-51372, in settlement of certain put option obligations. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (a) Financial Statements of Business Acquired. None. (b) Pro Forma Financial Information. None. (c) Exhibits. The Exhibits to this Form 8-K are listed on the Exhibit Index. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 5, 2002 IVAX CORPORATION By: /s/ Thomas E. Beier ------------------- Thomas E. Beier Senior Vice President-Finance and Chief Financial Officer Exhibit Index Exhibit 5.1 Opinion of Akerman, Senterfitt & Eidson, P.A. 10.31 Equity Option Confirmation Agreement, dated August 6, 2001.